Regulatory oversight that affects the firm's product-market environment continues to increase. Political management capital (PMC) describes firm expenditure committed to address the political and regulatory context. Neoinstitutional theory casts PMC as an institutionally expected normative response investors use when evaluating firm performance. Although limited evidence has suggested that firms benefit from PMC, the authors demonstrate its effects across financial outcomes including firm value, systematic risk, and idiosyncratic risk. Likewise, they examine how PMC interacts with a firm's product market through research-and-development (R&D) capital and advertising capital. Regression analysis of an unbalanced data set of 212 firms in the pharmaceutical and medical device industry, tracked from 2003 to 2014, reveals that while PMC improves investor expectations through firm value and systematic risk, it increases idiosyncratic risk. The authors find that PMC plays both substitutive and complementary roles with R&D such that increasing levels of both PMC and R&D weakens main effects. Political management capital has limited, but substitutive, effects with advertising likely because there is less regulatory oversight on advertising versus R&D in this industry. The authors explore these asymmetric effects, provide implications for neoinstitutional theory, and offer managerial insights.
AldrichHoward E. (1979), Organizations and Environments. Englewood Cliffs, NJ: Prentice Hall.
2.
Al-UbaydliOmar, and McLaughlinPatrick A. (2015), “RegData: A Numerical Database on Industry-Specific Regulations for All United States Industries and Federal Regulations, 1997–2012,”Regulation & Governance, 11 (1), 109–23.
3.
BaronDavid P. (1995), “Integrated Strategy: Market and Nonmarket Components,”California Management Review, 37 (Winter), 47–65.
4.
BaronDavid P. (1999), “Integrated Market and Nonmarket Strategies in Client and Interest Group Politics,”Business and Politics, 1 (1), 7–34.
5.
BartramSohnke M., BrownGregory, and StulzRene M. (2012), “Why Are U.S. Stocks More Volatile?”Journal of Finance, 67 (4), 1329–71.
BennerMary J. (2007), “The Incumbent Discount: Stock Marketing Categories and Response to Radical Technological Change,”Academy of Management Review, 32 (3), 703–20.
8.
BharadwajSundar G., TuliKapil R., and BonfrerAndre (2011), “The Impact of Brand Quality on Shareholder Wealth,”Journal of Marketing, 75 (5), 88–104.
9.
BlauBenjamin M., BroughTyler J., and ThomasDiana W. (2013), “Corporate Lobbying, Political Connections, and the Bailout of Banks,”Journal of Banking & Finance, 37 (8), 3007–17.
10.
BonardiJean-Philippe, HolburnGuy L.F., and Vanden BerghRichard G. (2006), “Nonmarket Strategy Performance: Evidence from U.S. Electric Utilities,”Academy of Management Journal, 49 (6), 1209–28.
11.
BorghesiRichard, and ChangKiyoung (2015), “The Determinants of Effective Corporate Lobbying,”Journal of Economics and Finance, 39 (3), 606–24.
12.
BorisovAlexander, GoldmanEitan, and GuptaNandini (2016), “The Corporate Value of (Corrupt) Lobbying,”Review of Financial Studies, 29 (4), 1039–71.
CarhartMark M. (1997), “On Persistence in Mutual Fund Performance,”Journal of Finance, 52 (1), 57–82.
15.
ChakravartyAnindita, and GrewalRajdeep (2011), “The Stock Market in the Driver's Seat! Implications for R&D and Advertising,”Management Science, 57 (9), 1595–609.
16.
ChaneyPaul K., FaccioMara, and ParsleyDavid (2011), “The Quality of Accounting Information in Politically Connected Firms,”Journal of Accounting and Economics, 51 (1/2), 58–76.
17.
ChenHui, ParsleyDavid, and YangYa-Wen (2015), “Corporate Lobbying and Firm Performance,”Journal of Business Finance & Accounting, 42 (3/4), 444–81.
18.
ChildJohn (1972), “Organization Structure, Environment and Performance: The Role of Strategic Choice,”Sociology, 6 (1), 1–22.
19.
ChungKee H., and PruittStephen W. (1994), “A Simple Approximation of Tobin's q,”Financial Management, 23 (3), 70–74.
20.
CooperMichael J., GulenHuseyin, and OvtchinnikovAlexei V. (2010), “Corporate Political Contributions and Stock Returns,”Journal of Finance, 65 (2), 687–724.
21.
DayGeorge S. (2011), “Closing the Marketing Capabilities Gap,”Journal of Marketing, 75 (4), 183–95.
22.
DiMaggioPaul J., and PowellWalter W. (1983), “The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational Fields,”American Sociological Review, 48 (2), 149–60.
23.
DingMin, EliashbergJehoshua, and StremerschStefan (2014), Innovation and Marketing in the Health Care Industry: Emerging Practices, Research, and Policies. New York: Springer.
24.
DonohueJulie (2006), “A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection,”Milbank Quarterly, 84 (4), 659–99.
25.
DotzelThomas, ShankarVenkatesh, and BerryLeonard L. (2013), “Service Innovativeness and Firm Value,”Journal of Marketing Research, 50 (2), 259–76.
26.
DrutmanLee (2015), The Business of America Is Lobbying: How Corporations Became Politicized and Politics Became More Corporate. Oxford, UK: Oxford University Press.
FaccioMara, MasulisRonald W., and McConnellJohn J. (2006), “Political Connections and Corporate Bailouts,”Journal of Finance, 61 (6), 2597–635.
32.
FismanRaymond, and WangYongxiang (2015), “The Mortality Cost of Political Connections,”Review of Economic Studies, 82 (4), 1346–82.
33.
FürstAndreas, LeimbachMartin, and PriggeJana-Kristin (2017), “Organizational Multichannel Differentiation: An Analysis of Its Impact on Channel Relationships and Company Sales Success,”Journal of Marketing, 81 (1), 59–82.
34.
GermannFrank, EbbesPeter, and GrewalRajdeep (2015), “The Chief Marketing Officer Matters!”Journal of Marketing, 79 (3), 1–22.
35.
GiebelhausenMichael, ChunHaeEun Helen, CroninJosephJr., and HultG. Tomas (2016), “Adjusting the Warm-Glow Thermostat: How Incentivizing Participation in Voluntary Green Programs Moderates Impact on Service Satisfaction,”Journal of Marketing, 80 (4), 56–71.
GrewalRajdeep, and DharwadkarRavi (2002), “The Role of the Institutional Environment in Marketing Channels,”Journal of Marketing, 66 (3), 82–97.
38.
GuFlora F., HungKineta, and TseDavid K. (2008), “When Does Guanxi Matter? Issues of Capitalization and Its Dark Sides,”Journal of Marketing, 72 (4), 12–28.
39.
HadaniMichael, and SchulerDouglas A. (2013), “In Search of El Dorado: The Elusive Financial Returns on Corporate Political Investment,”Strategic Management Journal, 34 (2), 165–81.
40.
HanKyuhong, MittalVikas, and ZhangYan (2017), “Relative Strategic Emphasis and Firm Idiosyncratic Risk: The Moderating Role of Relative Performance and Demand Instability,”Journal of Marketing, 81 (4), 25–44.
41.
HansenLars P. (1982), “Large Sample Properties of Generalized Method of Moments Estimators,”Econometrica, 50 (4), 1029–54.
42.
HanssensDominique M., and PauwelsKoen (2016), “Demonstrating the Value of Marketing,”Journal of Marketing, 80 (6), 173–90.
43.
HeckmanJames J. (1979), “Sample Selection Bias as a Specification Error,”Econometrica, 47, 153–62.
HomburgChristian, and BuceriusMatthew (2005), “A Marketing Perspective on Mergers and Acquisitions: How Marketing Integration Affects Postmerger Performance,”Journal of Marketing, 69 (1), 95–113.
46.
IizukaToshiaki, and JinGinger Zhe (2005), “The Effect of Prescription Drug Advertising on Doctor Visits,”Journal of Economics & Management Strategy, 14 (3), 701–27.
47.
ImKyung So, PesaranM. Hashem, and ShinYongheol (2003), “Testing for Unit Roots in Heterogeneous Panels,”Journal of Econometrics, 115 (1), 53–74.
48.
JindalNiket, and McAlisterLeigh (2015), “The Impacts of Advertising Assets and R&D Assets on Reducing Bankruptcy Risk,”Marketing Science, 34 (4), 555–72.
49.
JoshiAmit, and HanssensDominque M. (2010), “The Direct and Indirect Effects of Advertising Spending on Firm Value,”Journal of Marketing, 74 (1), 20–33.
50.
KashyapVishal, and MurthaBrian R. (2017), “The Joint Effects of Ex Ante Contractual Completeness and Ex Post Governance on Compliance in Franchised Marketing Channels,”Journal of Marketing, 81 (3), 130–53.
KolsariciCeren, and VakratsasDemetrios (2010), “Category- Versus Brand-Level Advertising Messages in a Highly Regulated Environment,”Journal of Marketing Research, 47 (6), 807–21.
KrasnikovAlexander, and JayachandranSatish (2008), “The Relative Impact of Marketing, Research-and-Development, and Operations Expenditures on Firm Performance,”Journal of Marketing, 72 (4), 1–11.
55.
KumarV. (2015), “Evolution of Marketing as a Discipline: What Has Happened and What to Look For,”Journal of Marketing, 79 (1), 1–9.
56.
LeeRuby, and GrewalRajdeep (2004), “Strategic Responses to New Technologies and Their Impact on Firm Performance,”Journal of Marketing, 68 (4), 157–71.
57.
LewbelArthur (2012), “Using Heteroscedasticity to Identify and Estimate Mismeasured and Endogenous Regressor Models,”Journal of Business & Economic Statistics, 30 (1), 67–80.
58.
LiJulie Juan, PoppoLaura, and ZhouKevin Zheng (2008), “Do Managerial Ties in China Always Produce Value? Competition, Uncertainty, and Domestic vs. Foreign Firms,”Strategic Management Journal, 29 (4), 383–400.
59.
LiJulie Juan, ZhouKevin Zheng, and ShaoAlan T. (2009), “Competitive Position, Managerial Ties, and Profitability of Foreign Firms in China: An Interactive Perspective,”Journal of International Business Studies, 40 (2), 339–52.
LiuQiang, and GuptaSachin (2014), “Direct-to-Consumer Advertising of Healthcare,” in Innovation and Marketing in the Health care Industry, DingMin, EliashbergJehoshaua, and StremerschStefan, eds. New York: Springer, 629–50.
LuoXueming, and BhattacharyaC.B. (2009), “The Debate over Doing Good: Corporate Social Performance, Strategic Marketing Levers, and Firm-Idiosyncratic Risk,”Journal of Marketing, 73 (6), 198–213.
64.
LuxSean, CrookT. Russell, and WoehrDavid J. (2011), “Mixing Business with Politics: A Meta-Analysis of the Antecedents and Outcomes of Corporate Political Activity,”Journal of Management, 37 (1), 223–47.
65.
MalsheAshwin, and AgarwalManoj K. (2015), “From Finance to Marketing: The Impact of Financial Leverage on Customer Satisfaction,”Journal of Marketing, 79 (5), 21–38.
66.
MazzucatoMariana, and TancioniMassimiliano (2008), “Innovation and Idiosyncratic Risk: An Industry- and Firm-Level Analysis,”Industrial and Corporate Change, 17 (4), 779–811.
67.
McAlisterLeigh, SrinivasanRaji, and KimMinChung (2007), “Advertising, Research and Development, and Systematic Risk of the Firm,”Journal of Marketing, 71 (1), 35–48.
68.
MeyerJohn W., and RowanBrian (1977), “Institutionalized Organizations: Formal Structure as Myth and Ceremony,”American Journal of Sociology, 83 (2), 340–63.
69.
MishraSaurabh, and ModiSachin B. (2016), “Corporate Social Responsibility and Shareholder Wealth: The Role of Marketing Capability,”Journal of Marketing, 80 (1), 26–46.
70.
MizikNatalie, and JacobsonRobert (2003), “Trading Off Between Value Creation and Value Appropriation: The Financial Implications of Shifts in Strategic Emphasis,”Journal of Marketing, 67 (1), 63–76.
NarayananSridhar, DesirajuRamarao, and ChintaguntaPradeep K. (2004), “Return on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions,”Journal of Marketing, 68 (4), 90–105.
73.
OliverKelsey (2017), “Brand Name Healthcare Manufacturing in the US,” IBISWorld Industry Report 32541a (April).
74.
OsingaErnst C., LeeflangPeter S.H., SrinivasanShuba, and WieringJaap E. (2011), “Why Do Firms Invest in Consumer Advertising with a Limited Sales Response? A Shareholder Perspective,”Journal of Marketing, 75 (1), 109–24.
75.
PapiesDominik, and van HeerdeHarald J. (2017), “The Dynamic Interplay Between Recorded Music and Live Concerts: The Role of Piracy, Unbundling, and Artist Characteristics,”Journal of Marketing, 81 (4), 67–87.
PengMike W., and LuoYadong (2000), “Managerial Ties and Firm Performance in a Transition Economy: The Nature of a Micro-Macro Link,”Academy of Management Journal, 43 (3), 486–501.
78.
PoppoLaura, and ZengerTodd (2002), “Do Formal Contracts and Relational Governance Function as Substitutes or Complements?”Strategic Management Journal, 23 (8), 707–25.
79.
RegoLopo L., BillettMatthew T., and MorganNeil A. (2009), “Consumer-Based Brand Equity and Firm Risk,”Journal of Marketing, 73 (6), 49–67.
80.
RosenthalMeredith B., BerndtErnst R., DonohueJulie M., FrankRichard G., and EpsteinArnold M. (2002), “Promotion of Prescription Drugs to Consumers,”New England Journal of Medicine, 346 (February), 498–505.
81.
SabooAlok R., SharmaAmalesh, ChakravartyAnindita, and KumarV. (2017), “Influencing Acquisition Performance in High-Technology Industries: The Role of Innovation and Relational Overlap,”Journal of Marketing Research, 54 (2), 219–38.
82.
ScottW. Richard (2014), Institutions and Organizations: Ideas, Interests, and Identities, 4th ed. Thousand Oaks, CA: Sage Publications.
83.
ShengShibin, ZhouKevin Zheng, and LiJulie Juan (2011), “The Effects of Business and Political Ties on Firm Performance: Evidence from China,”Journal of Marketing, 75 (1), 1–15.
84.
SiggelkowNicolaj (2002), “Misperceiving Interactions Among Complements and Substitutes,”Management Science, 48 (7), 900–16.
SrivastavaRajendra K., ShervaniTasadduq A., and FaheyLiam (1998), “Market-Based Capital and Shareholder Value: Framework for Analysis,”Journal of Marketing, 62 (1), 2–18.
87.
StockJames H., and WatsonMark W. (2011), Introduction to Econometrics. Boston: Pearson/Addison Wesley.
88.
ThomazFelipe, and SwaminathanVanitha (2015), “What Goes Around Comes Around: The Impact of Marketing Alliances on Firm Risk and the Moderating Role of Network Density,”Journal of Marketing, 79 (5), 63–79.
89.
TiptonMartha Myslinski, BharadwajSundar G., and RobertsonDiana C. (2009), “Regulatory Exposure of Deceptive Marketing and Its Impact on Firm Value,”Journal of Marketing, 73 (6), 227–43.
90.
TuliKapil R., and BharadwajSundar G. (2009), “Customer Satisfaction and Stock Returns Risk,”Journal of Marketing, 73 (6), 184–97.
91.
WaterhouseBenjamin C. (2014), Lobbying America: The Politics of Business from Nixon to NAFTA. Princeton, NJ: Princeton University Press.
92.
WeinbergSandy (2011), Cost-Contained Regulatory Compliance for the Pharmaceuticals, Biologics, and Medical Device Industries. Hoboken, NJ: John Wiley & Sons.
93.
WooldridgeJeffrey M. (2010), Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press.
94.
WosinskaMarta (2002), “Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products,” Harvard Business School Working Paper No. 02-04.
95.
YuFrank, and YuXiaoyun (2011), “Corporate Lobbying and Fraud Detection,”Journal of Financial and Quantitative Analysis, 46 (6), 1865–91.
96.
ZajacEdward J., and WestphalJames D. (2004), “The Social Construction of Market Value: Institutionalization and Learning Perspectives on Stock Market Reactions,”American Sociological Review, 69 (3), 433–57.
97.
ZellnerArnold (1962), “An Efficient Method of Estimating Seemingly Unrelated Regressions and Tests for Aggregation Bias,”Journal of the American Statistical Association, 57 (298), 348–68.
98.
ZhouKevin Zheng, JulieJuan Li, ShengShibin, and ShaoAlan T. (2014), “The Evolving Role of Managerial Ties and Firm Capabilities in an Emerging Economy: Evidence from China,”Journal of the Academy of Marketing Science, 42 (6), 581–95.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
